Ruby Mills opened higher at ₹493.20, compared with its previous close of ₹484.05. During today's session, the stock has traded between ₹472.10 and ₹509.90, with an average traded price of ₹485.55. It is currently showing an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Ruby Mills is now worth
₹ 33,432.00
giving a profit of
₹ 23,432.00 (234.32%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+8.00 (+1.65%)
Day High
₹509.90
Day Low
₹472.10
Day Open
₹493.20
Prev Close
₹484.05
Volume
9,536
Value Traded
₹0.46 Cr
1W Return
-0.44%
1M Return
8.12%
3M Return
28.22%
6M Return
111.11%
1Y Return
121.17%
Market Cap (₹ Cr.)
1,645
PE Ratio
37.10
PB Ratio
2.40
Dividend Yield
0.52%
ROE
6.46%
ROCE
6.14%
Book Value (₹)
201.66
Face Value (₹)
5.00
EPS (TTM)
3.50
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-0.44%
6 Week
-
1 Month
8.12%
3 Month
28.22%
9 Month
137.24%
Ruby Mills shareholders approve ₹2.50 dividend for FY26
Final dividend of ₹2.50 per share for FY26 approved by shareholders. All eight resolutions, including director re-appointments, passed with >99% support. Promoter group held 74.32% of votes polled on key ordinary resolutions. Remuneration for four key managerial personnel approved via special resolutions.
19 days agoRuby Mills dispatches 110th AGM notice and FY26 annual report
Ruby Mills dispatched 110th AGM notice and FY26 Annual Report via web link. Shareholders without registered emails received letters with access links. Final dividend of ₹2.50 per share proposed for FY26. Record date for dividend eligibility fixed at September 17, 2026. AGM scheduled for September 24, 2026, via VC/OAVM mode.
1mo agoRuby Mills to expand with 12MW solar power project
Ruby Mills plans to expand with a 12MW solar power project. The project marks a move toward renewable energy capacity for the company. Solar power generation at 12MW scale can support large manufacturing and commercial operations.
1mo agoRuby Mills sells The Ruby 33rd floor to Torrent Pharma for ₹124.08 crore
Ruby Mills sold 33rd-floor commercial space at The Ruby to Torrent Pharmaceuticals. Transaction value stands at ₹124.08 crore including parking spaces. Deal completed on August 19, 2026; disclosed on August 20, 2026. Buyer is unrelated to Ruby Mills promoters; not a related-party transaction.
1mo agoRuby Mills Q1 EBITDA jumps 134% to ₹255M; profit dips 2%
Ruby Mills Limited reported a Q1FY26 standalone net profit of ₹118.25 lakh, down 1.9% YoY. However, operational strength was evident with EBITDA jumping 134% to ₹255 million and margins expanding to 27.90%. Revenue grew 31.5% to ₹915 million, driven by real estate.
2mo agoRuby Mills resumes weaving ops at Dhamni Plant after illegal strike
Ruby Mills Ltd workers resumed work at the Dhamni Plant weaving division on July 07, 2026, ending an illegal strike that began on June 29, 2026. The resolution followed an undertaking given by the workers along with interventions by the local Labour Commissioner's office and police authorities. The company estimated a loss of standing charges of approximately Rs 35 Lakhs and is approaching the Regional Industrial Labour Court, Thane, for further action.
3mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹111.95 | +0.07% | ₹807.88 | 13.91 | -14.31% | |
| ₹210.00 | +2.26% | ₹101.15 | -2.00 | -22.82% |
An investment of ₹10,000 made 5 years ago in Ruby Mills is now worth
₹ 33,432.00
giving a profit of
₹ 23,432.00 (234.32%)
Note: Past profits do not guarantee future returns.